---
figid: PMC8556325__nihms-1748022-f0001
figtitle: KRAS pathway and targeted preclinical and clinical agents
organisms:
- NA
pmcid: PMC8556325
filename: nihms-1748022-f0001.jpg
figlink: /pmc/articles/PMC8556325/figure/F1/
number: F1
caption: Receptors in the EGFR family upstream of KRAS transmit extracellular signals
  to activate KRAS. KRAS is activated via GDP to GTP exchange catalyzed by GEFs such
  as SOS, whereas GAPs catalyze the GTPase activity of KRAS. Downstream signaling
  pathways include the RAF/MEK/ERK and PI3K/AKT/mTOR pathways, which result in the
  expression of genes that promote survival, growth, and metastasis. Inhibitors or
  other targeted agents in the upstream or downstream of KRAS signaling have been
  depicted. RASGAPs RAS GTPase activating proteins, RASGEFs RAS guanine exchange factors,
  CRBN cereblon, PROTACs proteolysis targeting chimeras, VHL Von Hippel–Lindau tumor
  suppressor
papertitle: 'Targeting KRAS in pancreatic cancer: new drugs on the horizon.'
reftext: Sahar F. Bannoura, et al. Cancer Metastasis Rev. ;40(3):819-835.
year: '2021'
doi: 10.1007/s10555-021-09990-2
journal_title: Cancer metastasis reviews
journal_nlm_ta: Cancer Metastasis Rev
publisher_name: ''
keywords: KRAS | Pancreatic cancer | KRASG12C | KRAS inhibitor | KRASG12C inhibitors
  | PROTAC | KRAS vaccine
automl_pathway: 0.9317427
figid_alias: PMC8556325__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8556325__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8556325__nihms-1748022-f0001.html
  '@type': Dataset
  description: Receptors in the EGFR family upstream of KRAS transmit extracellular
    signals to activate KRAS. KRAS is activated via GDP to GTP exchange catalyzed
    by GEFs such as SOS, whereas GAPs catalyze the GTPase activity of KRAS. Downstream
    signaling pathways include the RAF/MEK/ERK and PI3K/AKT/mTOR pathways, which result
    in the expression of genes that promote survival, growth, and metastasis. Inhibitors
    or other targeted agents in the upstream or downstream of KRAS signaling have
    been depicted. RASGAPs RAS GTPase activating proteins, RASGEFs RAS guanine exchange
    factors, CRBN cereblon, PROTACs proteolysis targeting chimeras, VHL Von Hippel–Lindau
    tumor suppressor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mlc2
  - Egfr
  - Sos
  - drk
  - ras
  - Ras64B
  - Ras85D
  - csw
  - 'Off'
  - 'On'
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Akt
  - Mtor
  - Tor
  - Ns1
  - EGFR
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - KRAS
  - HRAS
  - NRAS
  - PTPN11
  - MTG1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - SLC25A16
  - IVNS1ABP
---
